Rhodri Evans

Rhodri Evans

Auto-generated profile, based on publicly available information

Rhodri Evans

The Royal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2026 in Science Advances
Verified
Journal Article
Open access
APAmy C. Pickering
Amy C. Pickering
JGJamie Gorzynski
Jamie Gorzynski
GTGrace Taylor-Joyce
Grace Taylor-Joyce
RERhodri Evans
Rhodri Evans
WFWillow Fox
Willow Fox
JFJ. Ross Fitzgerald
J. Ross Fitzgerald
New pathogens typically arise from host jump events between species. Staphylococcus aureus is a multihost pathogen responsible for a global burden of human disease and a leading cause of intramammary infection in dairy cattle. Here, we demonstrate that following historical human-to-bovine host switch events, S. aureus has undergone adaptive metabolic remodeling in response to distinct nutrient availability in the dairy niche. In particular, we found that bovine S. aureus has evolved the capacity for protease-mediated degradation of casein, a protein abundant in bovine milk, to access nutrients for proliferation. This phenotype has evolved convergently in different S. aureus lineages via mutations in distinct gene loci driving overexpression of the protease aureolysin. Together, we have dissected a key host-adaptive trait, which facilitates the enzymatic release of nutrients from a substrate specific to the new host milieu. These findings highlight the remarkable evolutionary plasticity of a major bacterial pathogen underpinning its multihost species tropism.

3 November 2026 in Microbial Genomics
Verified
Journal Article
Open access
NRNatalie Ring
Natalie Ring
ALAlison S. Low
Alison S. Low
RERhodri Evans
Rhodri Evans
MKMarianne Keith
Marianne Keith
GPGavin Paterson
Gavin Paterson
JFJ. Ross Fitzgerald
J. Ross Fitzgerald
Antimicrobial resistance (AMR) presents a pressing need to ensure that the right antimicrobials are used to target the right microbes at the right time. Ideally, the appropriate antimicrobial is selected after patient samples have been cultured and assessed with antimicrobial sensitivity testing (AST). However, the time needed for culture-based diagnosis leads to immediate empirical treatment, often with broad-spectrum and/or high-tier antimicrobials. Direct nanopore metagenomic whole-genome sequencing to identify pathogens and predict their AMR is a rapid and patient-side alternative. A limitation of this approach is potential inconsistencies in i predicted AMR phenotypes. Here, we benchmarked the current performance of in silico AMR prediction strategies for nanopore-generated long-read data. Using real-world nanopore data paired with AST phenotyping for 201 samples representing 27 bacterial species, we assessed the impact of basecalling mode, data volume and assembly strategy and compared the performance of eight in silico AMR prediction tools with seven AMR databases. We found that basecalling accuracy mode does not significantly affect the overall accuracy of in silico AMR predictions but assembly strategy and data volume both do. Prediction tools using the ResFinder database scored best for balanced accuracy (0.80±0.02 for both ResFinder and ABRicate), whilst DeepARG scored best for sensitivity (0.65±0.03); predictions were more accurate for some antibiotic classes and genera than others. However, even the best-performing in silico AMR prediction strategy missed some resistance identified by lab-based AST. We conclude, therefore, that currently in silico AMR prediction can supplement lab-based AST but cannot yet replace it.

6 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NRNatalie Ring
Natalie Ring
ALAlison S Low
Alison S Low
RERhodri Evans
Rhodri Evans
MKMarianne Keith
Marianne Keith
GPGavin Paterson
Gavin Paterson
JFJ. Ross Fitzgerald
J. Ross Fitzgerald
Antimicrobial resistance (AMR) presents a pressing need to ensure that the right antimicrobials are used to target the right microbes at the right time. Ideally, the appropriate antimicrobial is selected after patient samples have been cultured and assessed with antimicrobial sensitivity testing (AST). However, the time needed for culture-based diagnosis leads to immediate empirical treatment, often with broad-spectrum and/or high-tier antimicrobials. Direct nanopore metagenomic whole genome sequencing to identify the pathogens and predict their antimicrobial resistance is a rapid and patient-side alternative. A limitation of this approach is the inconsistency of in silico predicted AMR phenotypes. Here, we benchmarked the current performance of in silico AMR prediction strategies for nanopore-generated long read data. Using nanopore data paired with AST phenotyping for 201 samples, we assessed the impact of basecalling mode, data volume, and assembly strategy to compare the performance of eight in silico AMR prediction tools with seven AMR databases. We found that basecalling accuracy mode does not affect the overall accuracy of in silico AMR predictions, but assembly strategy and data volume both do. Prediction tools using the ResFinder database scored best for balanced accuracy (0.8 for both ResFinder and ABRicate), whilst DeepARG scored best for sensitivity (0.65). However, even the best performing in silico AMR prediction strategy missed some resistance identified by lab-based AST. In silico AMR prediction can therefore supplement lab-based AST, but cannot yet replace it.

7 August 2026
Verified
Preprint
Open access
RERhodri Evans
Rhodri Evans
OGOwen J. Glenn
Owen J. Glenn
DCDylan N. Clements
Dylan N. Clements
RPRobert Scott Pirie
Robert Scott Pirie
KPKathryn M. Pratschke
Kathryn M. Pratschke
NRNatalie Ring
Natalie Ring
Metagenomic whole genome sequencing is a powerful culture-independent approach for pathogen detection and microbiome analysis. However, sensitivity and cost-effectiveness are often limited by high levels of host DNA in the sequenced samples. Here, we describe a novel bead-based host-depletion method, adapted from a respiratory metagenomics workflow, in which selective physical disruption of host cells is followed by magnetic bead capture of released host DNA, while intact bacterial cells are retained in the supernatant for downstream extraction. We evaluated this bead-based method using mock samples, a bacterial dilution series, and clinical specimens. In mock samples with Staphylococcus aureus, Escherichia coli or Pseudomonas aeruginosa combined with THP-1 human cells, bead-based depletion host DNA by up to 99% and significantly improved the ratio of bacterial-to-host DNA, although bacterial DNA was also significantly reduced. A serial dilution experiment showed that performance was strongly influenced by bacterial biomass, with the greatest benefit observed when bacterial input was moderate-to-high. In clinical samples, host-derived reads were reduced across all samples; in some cases, this enabled the detection of pathogens above the diagnostic abundance threshold. Our findings demonstrate that bead-based host depletion is a promising approach for enhancing microbial representation in metagenomic samples.